IFNA1 and systemic lupus erythematosus: The presence of increased IFNα levels in SLE patients’ sera, that also correlated with disease activity, is largely known, suggesting a pathogenetic role of type I IFN in SLE clinical manifestations [148,149,150,151,152,153,154,155].